Arkansas is currently in Phase 1-B
The COVID-19 vaccine is an important tool in ending the COVID-19 pandemic.
Wearing masks and social distancing help reduce your chance of being exposed
to the virus or spreading it to others, but these measures are not enough.
Vaccines will work with your immune system so it will be ready to fight
the virus if you are exposed. The combination of getting vaccinated and
following CDC recommendations to protect yourself and others will offer
the best protection from COVID-19.
Currently, Arkansas is in Phase 1-B of the Arkansas Department of Health
COVID-19 Vaccination Program, which includes individuals 70 and older
and educators. There simply aren't currently enough vaccines available
for all adults who want to receive it. As supply increases, Baxter Regional
is working with our community partners to administer vaccines.
Important facts about the COVID-19 vaccine:
Vaccines won’t end the pandemic; other protections will continue.
Please continue to cover your mouth and nose with a mask when around others,
stay at least 6 feet away from others, avoid crowds, and wash your hands often.
No vaccine is 100% effective, but this will give us the best COVID-19 protection.
Two vaccines, Pfizer-BioNTech and Moderna, have been approved Emergency
Use Authorizations (EUA) from the U.S. Food and Drug Administration (FDA).
More are being developed. Baxter Regional has only received and admistered
the Pfizer-BioNTech vaccine to date.
The available vaccines are two shots, given 3-4 weeks apart.
COVID-19 vaccines are available at no cost to the patient.
Supplies are limited, but will increase over time.
After COVID-19 vaccination, you may have some side effects of flu-like
symptoms. This is a normal sign that your body is building protection.
Arkansas Department of Health COVID-19 Vaccination Program
COVID 19 FAQs | Arkansas Department of Health
COVID-19 FAQs | CDC
Benefits of Getting a COVID-19 Vaccine | CDC
Vaccine Recipient Fact Sheet | EUA | Pfizer-BioNTech COVID-19 Vaccine
Vaccine Recipient Fact Sheet | EUA | Moderna COVID-19 Vaccine